Procedure Deep-Dive · November 18, 2026

Fibrous Dysplasia and McCune-Albright Syndrome: Facial Asymmetry, Bone Contouring, the Optic Nerve, Café-au-Lait Spots, Lasers, and Regrowth

Some people who ask a cosmetic practice to fix a fuller cheek, a heavier brow, or a jaw that is bigger on one side do not have a soft tissue problem at all. They have fibrous dysplasia, a rare condition in which normal bone is replaced by softer, expanding fibrous bone, sometimes as part of McCune-Albright syndrome. Filler and masseter Botox will not touch it. Bone contouring can help, but the bone can grow back, the optic nerve is often nearby, and the hormones matter. Here is what patients and practices should settle first.

By The Editorial Desk

18 min read

A woman in her late twenties with long straight dark brown hair, wearing an oversized mustard-yellow ribbed knit sweater, seated at a light wooden table beside a bright window with her chin resting on one hand, looking at the camera with a calm, thoughtful expression

She is 31, works in hospital billing, and has spent most of her adult life tilting her head slightly to the left in photographs. Her right cheek sits fuller and higher than her left, and the right side of her forehead bulges a little above the brow. A med spa told her two years ago that she had "uneven fat pads" and offered filler on the left to balance it. It helped for a few months. A second injector suggested masseter Botox for what looked like a heavier right jaw angle. That did nothing. When she finally booked a surgical consultation to ask about cheek reduction, the surgeon pressed on the cheek, asked whether it had changed over the years, and ordered a CT scan before saying another word about surgery.

The scan showed what the earlier visits had missed. The bone of her right cheek, upper jaw, and part of the floor and outer wall of her eye socket had the hazy, "ground glass" look of fibrous dysplasia. Her cheek was not full because of fat. It was full because the bone itself had expanded.

This is not a common story, but it is a consequential one. Fibrous dysplasia can look, at a glance, like ordinary facial asymmetry, and the people who have it often go looking for cosmetic help long before anyone names the condition. The treatment options are real, and some of them are surgical, but they belong to a different category from filler and neurotoxin, and the planning involves the eye, the hormones, and the long-term behavior of the bone in ways that a typical cosmetic consultation does not cover.

Fibrous dysplasia and McCune-Albright syndrome: what the bone is doing and why the face is so often involved

The short answer: fibrous dysplasia is a noninherited condition in which a mutation that arises early in development causes patches of bone to be replaced by expanding fibrous, poorly mineralized tissue, and the skull and face are among the most commonly affected sites.

The cause is a change in a gene called GNAS that happens after conception, in one cell of the developing embryo. Every cell descended from that original cell carries the change, and every other cell does not. That is why the condition is patchy: the affected bone can be a single site, or many sites scattered across the skeleton, depending on how early the mutation occurred and where the descendant cells ended up. Because the change is not present in egg or sperm cells, fibrous dysplasia is not passed from parent to child. That is one of the first things patients with children want to know.

In the affected bone, the cells that should be building mature, organized bone instead produce a disorganized mix of fibrous tissue and weak, immature bone. On a CT scan this has a characteristic hazy appearance that radiologists call ground glass. The bone often expands outward as it is replaced, which is where the visible asymmetry comes from.

The terms patients will hear:

  • Monostotic fibrous dysplasia involves a single bone. In the face, a single area of the upper jaw or cheekbone is a common example.
  • Polyostotic fibrous dysplasia involves several bones, sometimes many, and usually on one side of the body more than the other.
  • McCune-Albright syndrome is the combination of fibrous dysplasia with café-au-lait skin patches and one or more overactive hormone glands. The classic hormone problems include early puberty, an overactive thyroid, excess growth hormone, and a kidney phosphate leak driven by a hormone called FGF23 that the abnormal bone produces. McCune-Albright syndrome is rare, with prevalence estimates ranging from roughly 1 in 100,000 to 1 in 1,000,000.
  • Craniofacial fibrous dysplasia is the term for involvement of the skull and facial bones. It is present in the large majority of people with the polyostotic form and is common in the monostotic form as well.

A few facts frame what matters to a cosmetic practice:

  • The lesions are most active in childhood and adolescence. In many adults the bone becomes relatively quiet, growing slowly or not at all. "Quiet" is not the same as "finished," though, and pregnancy, untreated growth hormone excess, and surgery itself can all coincide with renewed activity in some patients.
  • The condition has an international consensus guideline. In 2019 an international group of specialists published consensus recommendations for fibrous dysplasia and McCune-Albright syndrome in the Orphanet Journal of Rare Diseases. Much of what follows reflects that document and the long research program at the US National Institutes of Health, which has followed one of the largest groups of patients in the world.
  • It is not a cancer, and it rarely becomes one. Malignant change into a bone sarcoma is uncommon, reported in well under one percent of patients in most series, with higher risk in bone previously treated with radiation and in people with uncontrolled growth hormone excess. Radiation therapy is not a treatment for fibrous dysplasia.
  • Many adults have never been formally diagnosed. A person with a single, slowly growing facial lesion may have been told for years that one side of the face is "just bigger." The asymmetry tends to involve bone that the patient can feel is firm, and it tends to have changed over time rather than being present unchanged from birth.

The earlier piece on facial and breast asymmetry lays out the normal range of facial unevenness. Fibrous dysplasia sits outside that range, and the clue is usually in the history: a cheek, brow, or jaw that grew asymmetric over years and feels like bone under the fingers.

Before any cosmetic work: telling bone from soft tissue, and the CT scan that should come first

The short answer: a face that is fuller on one side because of firm, expanded bone needs imaging and a diagnosis before anyone injects, shaves, or implants anything, and the first test is usually a CT scan of the facial bones.

The reason this matters is simple. Cosmetic treatments are matched to the tissue causing the problem. Filler adds volume. Neurotoxin shrinks muscle. Liposuction and buccal fat reduction remove fat. None of them changes bone. A patient whose fuller cheek comes from fibrous dysplasia who receives filler on the opposite side to "even it out" has been treated for the wrong diagnosis, and the bone underneath can keep doing what it was doing.

The conditions that can look alike, at least at first, include:

  • Masseter muscle enlargement, which makes the lower jaw angle look heavy and is the reason masseter Botox for jawline slimming is popular. It is soft, it tightens when the patient clenches, and it shrinks with neurotoxin. Bone does none of those things.
  • Parotid gland swelling, which fills out the area in front of the ear and over the jaw angle. The earlier piece on swollen parotid glands and a wide jaw covers that list.
  • Hemifacial microsomia and Parry-Romberg syndrome, which make one side of the face smaller rather than bigger. Patients sometimes misread which side is "the problem." The pieces on hemifacial microsomia in adults and facial wasting and Parry-Romberg syndrome cover those conditions.
  • Old, healed facial fractures, which can leave a flat or prominent cheekbone. The piece on old facial fractures and cosmetic surgery explains the differences.
  • Acromegaly, in which excess growth hormone enlarges the jaw, brow, nose, and lips on both sides. It also overlaps with McCune-Albright syndrome, which can cause growth hormone excess, and the piece on acromegaly and cosmetic surgery covers why surgery waits for hormone control.
  • Other bone conditions, including ossifying fibroma, Paget's disease of bone in older adults, and the thickened bone that can sit over a meningioma. These are the reason imaging is read by a radiologist and not guessed at in a consultation room.

What a careful workup usually includes, adapted to the patient:

  • A CT scan of the face and skull. CT is the main test for craniofacial fibrous dysplasia. It shows the extent of the lesion, the relationship to the eye socket, the optic canal, the sinuses, the teeth, and the skull base, and it gives a baseline to compare against later.
  • A bone scan or other whole skeleton survey. The consensus guideline recommends mapping the full skeleton at diagnosis, because a person with a facial lesion may also have lesions in the legs, ribs, pelvis, or spine. Some of those raise fracture risk, which matters for positioning and recovery after any operation.
  • Blood tests aimed at McCune-Albright syndrome. These usually include phosphate, thyroid function, and growth hormone screening, among others chosen by the endocrinologist. A low phosphate level from FGF23 excess weakens bone further and is treatable.
  • An eye examination. If the lesion involves the bones around the eye, a baseline exam by an ophthalmologist, with a check of vision, color vision, visual fields, and the optic nerve, belongs in the chart before anyone discusses surgery.
  • A biopsy only when the picture is unclear. In many cases the CT appearance plus the clinical picture is enough. When it is not, tissue sampling may be needed, and genetic testing of the lesion for the GNAS change can sometimes help.

The surgeon who ordered the CT scan for the billing specialist in the opening did not do anything unusual. She did what any surgeon should do with a firm, slowly progressive asymmetry: she stopped treating it as cosmetic until she knew what it was.

The optic nerve, the eye socket, and the hormones: what has to be known before bone surgery near the face

The short answer: fibrous dysplasia often surrounds the canal that carries the optic nerve, but vision loss is uncommon, preventive decompression of the nerve is generally not recommended, and untreated growth hormone excess raises the risk, so the eye exam and the endocrine workup both come before any contouring.

This is the part of the planning most likely to surprise patients. When fibrous dysplasia involves the bones at the base of the skull, it frequently encases the optic canal, the bony tunnel that carries the nerve from the eye to the brain. On a scan, that looks alarming. It seems intuitive that the bone should be removed to "decompress" the nerve before it squeezes. The evidence points the other way.

What the research and the consensus guideline say:

  • Encasement is common. Vision loss is not. Large studies from the National Institutes of Health found that most people whose optic canal was surrounded by fibrous dysplasia had normal vision, and that the narrowing on the scan did not predict who would lose sight.
  • Preventive optic nerve decompression is generally not advised. Surgery to unroof the optic canal in a person with normal vision carries its own risk of damaging the nerve, and the consensus guideline recommends regular monitoring rather than prophylactic surgery. Decompression is reserved for people with documented, worsening vision loss.
  • Sudden vision change is an emergency. The fast problems in craniofacial fibrous dysplasia usually come from something else growing quickly inside or next to the lesion, such as an aneurysmal bone cyst, a sinus mucocele, or bleeding. A patient who notices rapid swelling, eye pain, double vision, or blurred vision should be seen the same day.
  • Growth hormone excess changes the risk. In McCune-Albright syndrome, excess growth hormone is associated with larger craniofacial lesions, a higher likelihood of optic neuropathy, and a higher chance that bone grows back after surgery. Treating it, usually with medication, is part of protecting the face and the eye.
  • The eye socket can be pushed out of shape. Fibrous dysplasia of the orbit can move the eye forward (proptosis) or downward or sideways (orbital dystopia), and can cause double vision. The earlier piece on thyroid eye disease and eyelid surgery covers a different cause of bulging eyes, but the principle carries over: eyelid work on an eye that sits in the wrong position starts with the bone, not the lid.

The hormone side of McCune-Albright syndrome matters for anesthesia, too. An overactive thyroid that is not controlled before surgery raises the risk of a dangerous rise in heart rate and temperature under anesthesia, and the piece on thyroid disease before cosmetic surgery explains the standard approach. Growth hormone excess can enlarge the tongue and soft tissues of the airway and is associated with sleep apnea, which the anesthesiologist will want to know about. A history of cortisol excess in infancy is rare and usually long resolved, but it belongs in the history. Low phosphate from the kidney leak weakens bone and can be treated with phosphate and active vitamin D, and in some cases with newer targeted medications.

None of this means a patient with McCune-Albright syndrome cannot have facial surgery. It means the people who should sign off first are an endocrinologist and, for lesions near the eye, an ophthalmologist, and both of those visits should happen before anyone draws on the face with a marker.

"A scan that shows bone around the optic nerve looks like a reason to operate. For most people with fibrous dysplasia and normal vision, the evidence says it is a reason to watch, measure, and leave the nerve alone."

Bone contouring, implants, filler, and jaw surgery: what actually helps a face shaped by fibrous dysplasia

The short answer: for most adults, the main surgical option is shaving or reshaping the expanded bone to restore symmetry, ideally once the lesion has become quiet, with the understanding that some regrowth is common and that a second operation years later is a realistic possibility.

Craniofacial surgeons usually describe two broad approaches. The first is contouring, sometimes called debulking or shaving: the surgeon reduces the excess bone with burrs or ultrasonic instruments until the contour matches the other side as closely as possible. The second is more complete removal of the affected bone, followed by reconstruction with bone grafts or custom implants. Complete removal is more realistic in some areas, such as parts of the forehead and the outer skull, than in others, such as the cheek, upper jaw, and skull base, where the lesion merges with structures that cannot be removed.

What patients should understand about contouring:

  • Timing matters. Surgery performed in childhood or during active growth is followed by regrowth more often than surgery in adults whose lesions have quieted. Many teams prefer to wait for skeletal maturity when the indication is appearance alone, while acting sooner for problems such as worsening vision, severe pain, or a blocked airway or sinus.
  • Regrowth is common, not rare. Published series report that a meaningful share of patients, including adults, show measurable regrowth after contouring, and a portion go on to a second procedure. Patients should hear that number from their surgeon in plain terms, and should ask how the surgeon will follow the result with scans.
  • The bone bleeds. Fibrous dysplasia is often more vascular than normal bone, and debulking can involve more blood loss than a typical cosmetic bone procedure. Blood counts, iron status, and a plan for blood loss belong in the preparation. The piece on anemia and blood loss before and after cosmetic surgery explains why the starting hemoglobin matters.
  • The nerve that matters is not always the optic nerve. Contouring the cheek and upper jaw can involve the nerve that supplies sensation to the cheek and upper lip, and contouring near the skull base or ear can involve hearing and facial nerve structures. The surgeon should name the specific nerves at risk for the specific lesion.
  • This is craniofacial surgery, not a cosmetic add-on. The procedures resemble those described in the pieces on cheekbone reduction and jawline contouring, but the bone behaves differently, the margins are less predictable, and the surgeon should have experience with fibrous dysplasia specifically. Many patients are treated at academic centers with craniofacial teams.

The other tools, and where they fit:

  • Filler and fat grafting. These can camouflage asymmetry by adding volume to the smaller side, and some patients reasonably choose camouflage over bone surgery. That is a legitimate decision once the diagnosis is known and the lesion has been imaged. It is a mistake when it replaces the diagnosis. Filler or fat placed over the affected side does nothing to the underlying bone, and the piece on dermal fat grafts versus fat transfer for facial volume explains the tradeoffs between the volume options.
  • Facial implants. Implants are usually placed on the unaffected side to match the affected one, or used in reconstruction after bone is removed. Placing an implant directly on active fibrous dysplasia is generally avoided. The piece on cheek and jaw implants covers the general considerations.
  • Jaw surgery and orthodontics. Fibrous dysplasia of the upper or lower jaw can tilt the bite and displace teeth. Orthodontic movement and corrective jaw surgery have been performed in quiescent disease, but they are planned carefully because the bone can respond unpredictably. The piece on orthognathic jaw surgery versus jawline work explains when the bite, not the contour, is the real problem.
  • Rhinoplasty and the sinuses. Lesions in the upper jaw and sinuses can block the nasal airway, distort the nose, and cause chronic sinus problems. Nasal surgery in an affected face should be planned with the CT in hand, and the pieces on functional rhinoplasty and ultrasonic piezo rhinoplasty explain the instruments and goals involved.
  • Neurotoxin. Botox and similar products have no effect on the bone. They have a narrow role only if a separate, real muscle component is contributing to the appearance.

Two other details deserve a mention. A small number of people with fibrous dysplasia also have benign muscle tumors called myxomas, a combination known as Mazabraud syndrome, and any new soft lump near an affected bone should be imaged rather than assumed to be part of the bone lesion. And bone pain, which is common in fibrous dysplasia, is a separate problem from appearance. It is often treated with ordinary pain medicines and sometimes with bisphosphonates, which can ease pain but have not been shown to shrink lesions or improve contour.

Café-au-lait spots, medications, scans, and the long view: living with the condition after the operation

The short answer: the café-au-lait patches of McCune-Albright syndrome respond unpredictably to lasers, the bone medications have specific cautions around surgery, and anyone with craniofacial fibrous dysplasia needs a plan for periodic eye checks and imaging that continues long after any cosmetic result.

The skin patches in McCune-Albright syndrome usually look different from those in neurofibromatosis. They tend to have jagged, irregular borders, often described as resembling the coast of Maine, and they often stop at the midline of the body. They are common reasons for adults to ask about lasers.

What patients can expect from treating the patches:

  • Results are variable. Pigment lasers such as Q-switched and picosecond devices can lighten café-au-lait patches, but responses range from near complete clearing to little change, and the color often returns in part over months. The earlier piece on nevus of Ota and café-au-lait birthmarks explains the devices and why recurrence is so common, and the piece on neurofibromatosis type 1 and cosmetic surgery notes that jagged patches may respond somewhat better than smooth-edged ones.
  • Skin tone changes the risk. In darker skin, aggressive pigment treatment can leave lighter or darker marks that are harder to live with than the original patch. A test spot and patience are reasonable.
  • Sun exposure darkens them. Daily sun protection makes the patches less noticeable and reduces the chance of darkening after treatment.
  • Camouflage makeup works. For a patch on the face or neck, modern camouflage products can match skin tone well, and some patients decide that is enough.

The medication list deserves its own conversation with the surgeon and the anesthesiologist:

  • Bisphosphonates. Intravenous zoledronic acid and pamidronate are sometimes used for bone pain in fibrous dysplasia. They raise questions about jaw procedures and dental implants, and the piece on osteoporosis and cosmetic surgery explains the concern about osteonecrosis of the jaw. The risk is low at the doses used for most adults, but anyone planning jaw contouring or extractions should tell the surgeon about every dose.
  • Denosumab. This drug has been studied for fibrous dysplasia and can reduce lesion activity, but stopping it can cause a sharp rebound in bone turnover, with high calcium levels reported in some patients. Its timing around surgery should be planned by the prescribing physician, not adjusted by the patient.
  • Teriparatide and similar bone-building drugs. These are generally avoided in fibrous dysplasia because of a theoretical concern about stimulating abnormal bone. A patient who was prescribed one for low bone density elsewhere should make sure the prescriber knows about the fibrous dysplasia.
  • Hormone treatments. Medications for growth hormone excess, an overactive thyroid, and phosphate wasting should continue through surgery unless the endocrinologist says otherwise.

The long view includes monitoring that has nothing to do with appearance:

  • Periodic eye exams for anyone with lesions near the orbit or optic canal, at intervals set by the ophthalmologist.
  • Repeat imaging when the face changes, when symptoms appear, or at intervals the specialist recommends, especially after contouring.
  • Hearing checks for lesions involving the temporal bone near the ear.
  • Attention to pregnancy. Some patients report changes in lesion activity or pain during pregnancy. Planning elective facial bone surgery around a pregnancy is reasonable, and the endocrinologist and obstetrician should know about the condition.
  • Fracture awareness. For people with leg or hip lesions, falls in the first weeks after any surgery can be more consequential, and the bone survey from diagnosis should inform how the patient is moved and how soon they walk unassisted.

There is also the psychological side. People who have lived with an uneven face for years, especially those who were given cosmetic explanations that did not fit, sometimes arrive with understandable frustration. A careful screen for body dysmorphic disorder belongs in every cosmetic consultation, but in this group the more common issue is the opposite: a real, measurable bone problem that was dismissed as a matter of perception for too long. A good consultation acknowledges that history. For a plan this involved, a second consultation is sensible, preferably with a craniofacial team, and the piece on what a surgical quote covers is worth reading before the bill arrives, because CT scans, eye exams, hormone testing, and an overnight stay can change the total meaningfully. When surgery is done to relieve vision problems, sinus obstruction, or bite problems, insurance may cover part of it, and the documentation from the eye doctor and the scans will matter.

The honest summary

Fibrous dysplasia is a rare, noninherited condition in which patches of bone are replaced by expanding fibrous tissue, and the face and skull are among the most common places it shows up. Sometimes it is part of McCune-Albright syndrome, which adds café-au-lait patches and overactive hormone glands. Because it can look like ordinary asymmetry, people with it often seek cosmetic help first and receive filler or Botox aimed at the wrong tissue. A firm, slowly progressive fullness of the cheek, brow, or jaw deserves a CT scan before any cosmetic treatment. Bone around the optic nerve is common and usually does not require surgery; regular eye exams are the standard, and sudden vision change is an emergency. Growth hormone, thyroid, and phosphate problems should be found and treated before an operation. Bone contouring can restore a more balanced face, preferably once the lesion is quiet, but the bone bleeds, nerves can be at risk, and regrowth is common enough that a patient should expect follow-up scans and accept the possibility of a second procedure. Camouflage with filler, fat, or implants on the other side is a reasonable choice once the diagnosis is clear. Lasers can lighten café-au-lait patches, but results vary and recurrence is common. The right surgeon hears "one side of my face has always been bigger, and it's gotten worse" and orders a scan. The wrong one reaches for a syringe.